Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
Read all of this leaflet carefully before you receive this medicine because it contains important information for you.
What is in this leaflet
Flucelvax Tetra is a vaccine against flu (influenza). Flucelvax Tetra is prepared in cell cultures, and, therefore, is egg-free.
When a person is given the vaccine, the immune system (the body’s natural defence system) will produce its own protection against the influenza virus. None of the ingredients in the vaccine can cause flu.
Flucelvax Tetra is used to prevent flu in adults and children from 2 years of age.
The vaccine targets four strains of influenza virus following the recommendations by the World Health Organisation for the 2022/2023 SEASON.
You should not receive Flucelvax Tetra:
If you are allergic to:
Warnings and precautions
Talk to your doctor, pharmacist or nurse before receiving Flucelvax Tetra.
BEFORE receiving the vaccine.
As with all vaccines, Flucelvax Tetra may not fully protect all persons who are vaccinated.
Other medicines and Flucelvax Tetra
Tell your doctor or nurse if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription or if you have recently received any other vaccine. Flucelvax Tetra may be given at the same time as other vaccines.
Pregnancy and breast-feeding
Pregnancy:
Tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby. Influenza vaccines may be given in any trimester of pregnancy.
Breast-feeding:
Use of Flucelvax Tetra during breast-feeding has not been studied. Flucelvax Tetra may be given during breast-feeding.
Driving and using machines
Flucelvax Tetra has no or negligible effect on your ability to drive and use machines.
Flucelvax Tetra contains sodium chloride and potassium chloride
This vaccine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium free’. This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially ‘potassium free’
Flucelvax Tetra is given to you by your doctor or nurse as an injection into the muscle at the top of the upper arm (deltoid muscle).
Adults and children from 2 years of age:
One dose of 0.5 ml
If your child is younger than 9 years of age and has not been previously vaccinated against flu, a second dose should be given after at least 4 weeks.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects have been reported during clinical trials and during general use:
Very serious side effects
Tell your doctor immediately or go to the casualty department at your nearest hospital if you experience the following side effect – you may need urgent medical attention or hospitalisation:
Serious side effects
Tell your doctor immediately if you experience any of the following side effects – you may need medical attention:
Mild side effects
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Not known (frequency cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.* By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this vaccine out of the sight and reach of children. Store in a refrigerator (2 °C to 8 °C).
Do not freeze.
Keep the pre-filled syringe in the outer carton in order to protect from light.
Do not use this vaccine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Flucelvax Tetra contains
The active substances are influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains*:
A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Delaware/55/2019 CVR-45) 15 micrograms HA**
A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/11/2021, wild type) 15 micrograms HA**
B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) 15 micrograms HA**
B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type) 15 micrograms HA**
per 0.5 ml dose
..............................................
* propagated in Madin Darby Canine Kidney (MDCK) cells (this is the special cell culture in which the influenza virus is grown);
** haemagglutinin
This vaccine complies with the World Health Organisation (WHO) recommendation (northern hemisphere) and EU recommendation for the 2022/2023 SEASON.
The other ingredients are: sodium chloride, potassium chloride, magnesium chloride hexahydrate, disodium phosphate dihydrate, potassium dihydrogen phosphate and water for injections.
What Flucelvax Tetra looks like and contents of the pack
Flucelvax Tetra is a suspension for injection in a pre-filled syringe (ready to use syringe).
Flucelvax Tetra is a clear to slightly opalescent suspension.A single syringe contains 0.5 ml of suspension for injection.Flucelvax Tetra is available in packs containing 1 pre-filled syringe with or without needle or 10 pre- filled syringes with or without needles.
Not all pack sizes may be marketed.
Full name: Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
- Invented name part: Flucelvax Tetra
- Scientific name part: Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
- Strength part: 15 ug
- Pharmaceutical dose form part: Solution for injection
Name usage: English (Spain)
Authorised dose form:
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: active
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: EU/1/18/1326/001
Region:
Marketing authorisation holder: Seqirus Netherlands B.V.
Identifier:
Status: Active (2019-01-01)
Package 1 of 1
Description:
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 100000073498 (Cardboard)
Containing:
Manufactured Item
Dose form: suspension for injection in pre-filled syringe
Unit of presentation: Syringe
Ingredient
Role: active
Substance: INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) WHOLE
Ingredient
Role: active
Substance: INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) WHOLE
Ingredient
Role: active
Substance: INFLUENZA B VIRUS B/Singapore/WUH4618/2021 WHOLE
Ingredient
Role: active
Substance: INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE
Ingredient
Role: Excipient
Substance: Sodium chloride
Ingredient
Role: Excipient
Substance: Potassium chloride
Ingredient
Role: Excipient
Substance: MAGNESIUM CHLORIDE
Ingredient
Role: Excipient
Substance: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Ingredient
Role: Excipient
Substance: Potassium dihydrogen phosphate
Ingredient
Role: Excipient
Substance: Water for injections
Administrable Product (1 of 1)
Dose form: suspension for injection in pre-filled syringe
Unit of presentation: Syringe
Route of administration:
Ingredient
Role: active
Substance: INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) WHOLE
Ingredient
Role: active
Substance: INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) WHOLE
Ingredient
Role: active
Substance: INFLUENZA B VIRUS B/Singapore/WUH4618/2021 WHOLE
Ingredient
Role: active
Substance: INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE
Ingredient
Role: Excipient
Substance: Sodium chloride
Ingredient
Role: Excipient
Substance: Potassium chloride
Ingredient
Role: Excipient
Substance: MAGNESIUM CHLORIDE
Ingredient
Role: Excipient
Substance: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Ingredient
Role: Excipient
Substance: Potassium dihydrogen phosphate
Ingredient
Role: Excipient
Substance: Water for injections